Viewing Study NCT06340594



Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06340594
Status: COMPLETED
Last Update Posted: 2024-04-02
First Post: 2024-03-25

Brief Title: Single-stage ERCP and Laparoscopic Cholecystectomy for Cholecystocholedocholithiasis Which to Start With
Sponsor: Assiut University
Organization: Assiut University

Study Overview

Official Title: Single-stage Endoscopic Retrograde Cholangiopancreatography and Laparoscopic Cholecystectomy for Cholecystocholedocholithiasis Which to Start With
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Chronic calculous cholecystitis is associated with common bile duct CBD stones in approximately 12 of patients These patients need both cholecystectomy and CBD clearance of stones The standard for cholecystectomy is laparoscopic cholecystectomy LC and the mostly common treatment used for CBD clearance is Endoscopic Retrograde Cholangiopancreatography ERCP The two interventions can be combined to be done at the same time under single anesthesia session Studies of single stage ERCPLC showed confirmed the safety and efficacy of the combined technique However some surgeons start with the ERCP while others start with LCThe aim of this study is to compare the start with ERCP followed by LC to the start with LC followed by ERCP when the two techniques are combined at the same session for treatment of chronic calculous cholecystitis associated with CBD stones regarding efficacy and safety of the two approaches
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None